Effect of Splitting Mealtime Insulin Doses After Mixed Meals High in Fat and Protein
Primary Purpose
Type 1 Diabetes Mellitus
Status
Completed
Phase
Phase 4
Locations
Egypt
Study Type
Interventional
Intervention
: Insulin, lispro and regular insulin
Sponsored by
About this trial
This is an interventional treatment trial for Type 1 Diabetes Mellitus
Eligibility Criteria
Inclusion Criteria:
- Children and adolescents aged 6 - 18 years
- diagnosed with T1DM for at least 1 year
- using MDI regimen with advanced carbohydrate counting for at least 6 months
Exclusion Criteria:
Subjects with associated
- diabetic autonomic neuropathy
- hypothyroidism
- celiac disease.
Sites / Locations
- Sawsana Ewieda
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Active Comparator
Active Comparator
Active Comparator
Arm Label
Arm 1 (usual treatment)
Arm 2(splitted bolus dose, fast-acting insulin only)
Arm 3 (splitted bolus dose, fast acting insulin before the meal and regular insulin after the meal)
Arm Description
intervention A
intervention B
intervention C
Outcomes
Primary Outcome Measures
Capillary blood glucose levels before the test meals.
Capillary blood glucose levels measured by a calibrated finger-prick blood glucose meter before the test meals
Capillary blood glucose levels one hour after the test meals.
Capillary blood glucose levels measured by a calibrated finger-prick blood glucose meter one hour after the test meals
Capillary blood glucose levels two hours after the test meals.
Capillary blood glucose levels measured by a calibrated finger-prick blood glucose meter two hours after the test meals
Capillary blood glucose levels three hours after the test meals.
Capillary blood glucose levels measured by a calibrated finger-prick blood glucose meter three hours after the test meals
Capillary blood glucose levels four hours after the test meals.
Capillary blood glucose levels measured by a calibrated finger-prick blood glucose meter four hours after the test meals
Capillary blood glucose levels five hours after the test meals.
Capillary blood glucose levels measured by a calibrated finger-prick blood glucose meter five hours after the test meals
Capillary blood glucose levels six hours after the test meals.
Capillary blood glucose levels measured by a calibrated finger-prick blood glucose meter six hours after the test meals
Secondary Outcome Measures
assessment of serum cholesterol level three hours after the test meal following each intervention
serum cholesterol levels measured 3 hours after the test meals.
assessment of serum triglyceride level three hours after the test meal following each intervention
serum triglycerides levels measured 3 hours after the test meals.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT04783376
Brief Title
Effect of Splitting Mealtime Insulin Doses After Mixed Meals High in Fat and Protein
Official Title
Effect of Splitting Mealtime Insulin Doses Used for Mixed Meals High in Fat and Protein on Postprandial Blood Glucose Levels in Children and Adolescents With Type 1 Diabetes Mellitus Using Multiple Daily Injection Regimen
Study Type
Interventional
2. Study Status
Record Verification Date
March 2022
Overall Recruitment Status
Completed
Study Start Date
April 12, 2021 (Actual)
Primary Completion Date
November 25, 2021 (Actual)
Study Completion Date
March 3, 2022 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Sohag University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The current management of type 1 diabetes mellitus (T1DM) depends on the use of intensive insulin therapy - either by insulin pump therapy or multiple daily injection (MDI) therapy - and the use of carbohydrate counting to determine the mealtime bolus insulin dose according the carbohydrate contents of each meal or snack. However, several studies reported that the fat and protein contents of the meals can also affect the postprandial blood glucose levels and result in delayed postprandial hyperglycemia especially after high fat and protein meals.
There is no widely accepted regimen to calculate insulin required for the fat and protein contents of meals especially for patients using multiple daily injection regimen. This study aims to find a better method to cover the increased insulin requirements following mixed fat and protein meals. The study will compare the effect of splitting mealtime bolus insulin doses into pre-meal and post-meal portions to the standard regimen which involve giving bolus dose depending on carbohydrate content only with additional correction doses 2 to 3 hours after the meal to compensate for the postprandial hyperglycemia induced by fat and protein content of the meals.
Detailed Description
The study will include children and adolescents aged 6 - 18 years, diagnosed with T1DM for at least 1 year, using multiple daily injection regimen and carbohydrate counting. The study participants will be admitted at the pediatric department, Sohag University Hospital for 1 week to adjust insulin doses. adjustments will be made to basal doses, insulin to carbohydrate ratio (ICR), insulin sensitivity factor (ISF) if required.
The study participants will have three test lunch meals on 3 consecutive days consumed at the pediatric department, Sohag university hospital at 12 PM. The test meals will consist of two slices of a deep pan pizza base topped with tomato sauce, mozzarella full fat soft cheese, and minced beef. (weight: 150 g, carb. 40 g, fat: 15 g, protein: 20 g, total calories 360 kcal). The meal will be consumed within 20 minutes.
Blood glucose level before the meal should be between 80 to 150 mg/dl. Correction doses can be given 3 hours before the test if needed to bring the blood glucose level to the desired target range before the test meals.
The participant will be assigned to use each one of the following interventions on a separate day in a random sequence.
Intervention A: the participant will have a mealtime bolus dose of fast-acting insulin 10 minutes before the meal representing 100% of the dose calculated according to the carbohydrate content of the meal and the individual insulin to carbohydrate ratio (ICR). If hyperglycemia (blood glucose level >180 mg/dl) developed after 3 hours, the participant will receive an additional correction dose of fast-acting insulin calculated according to the individual insulin sensitivity factor (ISF).
Intervention B: the bolus insulin dose for the meal will be calculated according to the carbohydrate content of the meal and the individual insulin to carbohydrate ratio (ICR) and additional 30% of the calculated dose will added to cover the fat and protein content of the meal. This total dose will be divided into 2 portions. A premeal portion (60% of the total dose) will be given 10 minutes before the meal. The remaining 40% of the total dose will be given 30 minutes after the premeal dose. Both doses will be given as fast-acting insulin.
Intervention C: the bolus insulin dose for the meal will be calculated according to the carbohydrate content of the meal and the individual insulin to carbohydrate ratio (ICR) and additional 30% of the calculated dose will added to cover the fat and protein content of the meal. This total dose will be divided into 2 portions. A premeal portion (60% of the total dose) will be given 10 minutes before the meal as fast-acting insulin. The remaining 40% of the total dose will be given 30 minutes after the premeal dose as regular insulin.
Types of insulin: insulin lispro (Humalog 100 IU/mL) as fast-acting insulin and regular insulin (Humulin R) as regular insulin (Eli Lilly and Company, Indianapolis, IN, USA). Insulin doses will be calculated, splitted, approximated to the nearest 0.5 unit and given using Humapen Luxura half- unit increments insulin pens.
Capillary blood glucose level will be measured by a calibrated finger-prick blood glucose meter before the meals and every hour for the next 6 hours after the test meals. Moreover, venous blood glucose and serum cholesterol and triglycerides levels will be measured 3 hours after the test meals.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Type 1 Diabetes Mellitus
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
43 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Arm 1 (usual treatment)
Arm Type
Active Comparator
Arm Description
intervention A
Arm Title
Arm 2(splitted bolus dose, fast-acting insulin only)
Arm Type
Active Comparator
Arm Description
intervention B
Arm Title
Arm 3 (splitted bolus dose, fast acting insulin before the meal and regular insulin after the meal)
Arm Type
Active Comparator
Arm Description
intervention C
Intervention Type
Drug
Intervention Name(s)
: Insulin, lispro and regular insulin
Intervention Description
A: the participant will have a mealtime bolus dose of fast-acting insulin 10 minutes before the meal representing 100% of the dose calculated according to the carbohydrate content of the meal and the individual insulin to carbohydrate ratio
B: the bolus insulin dose for the meal will be calculated according to the carbohydrate content of the meal and the individual insulin to carbohydrate ratio and additional 30% of the calculated dose will added to cover the fat and protein content of the meal. This total dose will be divided into 2 portions. A premeal portion (60%) will be given 10 minutes before the meal and (40%) will be given 30 minutes after the premeal dose. Both doses will be given as fast-acting insulin.
C: the same as intervention B but the 40% of the total dose will be given as regular insulin.
Primary Outcome Measure Information:
Title
Capillary blood glucose levels before the test meals.
Description
Capillary blood glucose levels measured by a calibrated finger-prick blood glucose meter before the test meals
Time Frame
before the test meals.
Title
Capillary blood glucose levels one hour after the test meals.
Description
Capillary blood glucose levels measured by a calibrated finger-prick blood glucose meter one hour after the test meals
Time Frame
one hour after the test meal
Title
Capillary blood glucose levels two hours after the test meals.
Description
Capillary blood glucose levels measured by a calibrated finger-prick blood glucose meter two hours after the test meals
Time Frame
two hours after the test meal
Title
Capillary blood glucose levels three hours after the test meals.
Description
Capillary blood glucose levels measured by a calibrated finger-prick blood glucose meter three hours after the test meals
Time Frame
three hours after the test meal
Title
Capillary blood glucose levels four hours after the test meals.
Description
Capillary blood glucose levels measured by a calibrated finger-prick blood glucose meter four hours after the test meals
Time Frame
four hours after the test meal
Title
Capillary blood glucose levels five hours after the test meals.
Description
Capillary blood glucose levels measured by a calibrated finger-prick blood glucose meter five hours after the test meals
Time Frame
five hours after the test meal
Title
Capillary blood glucose levels six hours after the test meals.
Description
Capillary blood glucose levels measured by a calibrated finger-prick blood glucose meter six hours after the test meals
Time Frame
six hours after the test meal
Secondary Outcome Measure Information:
Title
assessment of serum cholesterol level three hours after the test meal following each intervention
Description
serum cholesterol levels measured 3 hours after the test meals.
Time Frame
3 hours after test meal
Title
assessment of serum triglyceride level three hours after the test meal following each intervention
Description
serum triglycerides levels measured 3 hours after the test meals.
Time Frame
3 hours after test meal
10. Eligibility
Sex
All
Minimum Age & Unit of Time
6 Years
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Children and adolescents aged 6 - 18 years
diagnosed with T1DM for at least 1 year
using MDI regimen with advanced carbohydrate counting for at least 6 months
Exclusion Criteria:
Subjects with associated
diabetic autonomic neuropathy
hypothyroidism
celiac disease.
Facility Information:
Facility Name
Sawsana Ewieda
City
Sohag
Country
Egypt
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Learn more about this trial
Effect of Splitting Mealtime Insulin Doses After Mixed Meals High in Fat and Protein
We'll reach out to this number within 24 hrs